Hormonal Control of Body Fuels

  • Douglas W. Wilmore
Part of the Reviewing Surgical Topics book series (RST)


The name “hormone,” derived from the Greek root meaning to excite, arouse, or set in motion, was proposed by Starling to describe chemical agents which are released from one group of cells, travel by the blood stream, and affect other cell populations. Huxley placed less emphasis on the mode of travel of these substances and suggested that the prime role of hormones is to transfer information from one set of cells to another, to evoke a response beneficial for the cell population as a whole.


Growth Hormone Sympathetic Nervous System Insulin Release Insulin Response Hormonal Control 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Starzl, T. E., Porter, K. A., and Putnam, C. W.: Intraportal insulin protects from the liver injury of portacaval shunt in dogs. Lancet, 2:1241, 1975.PubMedCrossRefGoogle Scholar
  2. 2.
    Samols, E., and Ryder, J. A.: Studies on tissue uptake of insulin in man using a differential immunoassay for endogenous and exogenous insulin.J. Clin. Invest., 40:2092, 1961.PubMedCrossRefGoogle Scholar
  3. 3.
    Tomasi, T., Sledz, D., Wales, J. K., and Recant, L.: Insulin half-life in normal and diabetic subjects. Proc., Soc. Exp. Biol., 126:315, 1967.Google Scholar
  4. 4.
    Yalow, R. S., and Berson, S. A.: Immunoassay of endogenous plasma insulin in man.J. Clin. Invest, 39:1157, 1960.PubMedCrossRefGoogle Scholar
  5. 5.
    Seltzer, H. S., Allen, E. W., Herron, A. L., and Brennan, M. T.: Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus.J. Clin. Invest, 46:323, 1967.PubMedCrossRefGoogle Scholar
  6. 6.
    Lerner, R. L., and Porte, D., Jr.: Relationships between intravenous glucose loads, insulin response and glucose disappearance rate. J. Clin. Endocr. Metab., 33:409, 1971.PubMedCrossRefGoogle Scholar
  7. 7.
    Samols, E., and Marks, V.: Interpretation of the intravenous glucose test. Lancet, 1:462, 1965.PubMedCrossRefGoogle Scholar
  8. 8.
    Hlad, C. J., Jr., Elrick, H., and Witten, T. A.: Studies on the kinetics of glucose utilization.J. Clin. Invest., 35:1139, 1956.PubMedCrossRefGoogle Scholar
  9. 9.
    Wilmore, D. W., Mason, A. D., Jr., and Pruitt, B. A., Jr.: Insulin response to glucose in hypermetabolic burn patients. Ann. Surg., 183:314, 1976.PubMedCrossRefGoogle Scholar
  10. 10.
    Munro, H. N., Fernstrom, J. D., and Wurtman, J. D.: Insulin, plasma amino acid imbalance, and hepatic coma. Lancet, 1:722, 1975.PubMedCrossRefGoogle Scholar
  11. 11.
    Pozefsky, T., Felig, P., and Tobin, J. D.: Amino acid balance across tissues of the forearm in postabsorptive man: Effects of insulin at two dose levels.J. Clin. Invest. 48:2273, 1969.PubMedCrossRefGoogle Scholar
  12. 12.
    Hinton, P., Allison, S. P., Littlejohn, S., and Lloyd, J.: Insulin and glucose to reduce catabolic response to injury in burn patients. Lancet, 1:767, 1971.PubMedCrossRefGoogle Scholar
  13. 13.
    Porte, D., Jr., and Robertson, R. P.: Control of insulin secretion by catecholamines, stress, and the sympathetic nervous system. Fed. Proc., 32:1792, 1973.PubMedGoogle Scholar
  14. 14.
    Iversen, J.: Adrenergic receptors and the secretion of glucagon and insulin from the isolated, perfused canine pancreas.J. Clin. Invest., 52:2102, 1973.PubMedCrossRefGoogle Scholar
  15. 15.
    Unger, R. H., and Orci, L.: The essential role of glucagon in the pathogenesis of diabetes mellitus. Lancet, 1:14, 1975.PubMedCrossRefGoogle Scholar
  16. 16.
    Alford, F. P., Bloom, S. R., Nabarro, J. D. N., Hall, R., Besser, G. M., Coy, D. H., Kastin, A. J., and Schally, A. V.: Glucagon control of fasting glucose in man. Lancet, 2:974, 1974.PubMedCrossRefGoogle Scholar
  17. 17.
    Unger, R. H.: Glucagon and the insulin:glucagon ratio in diabetes and other catabolic illnesses. Diabetes, 20:834, 1971.PubMedGoogle Scholar
  18. 18.
    Wilmore, D. W., Lindsey, C. A., Moylan, J. A., Faloona, G. R., Pruitt, B. A., Jr., and Unger, R. H.: Hyperglucagonemia after burns. Lancet, 1:73, 1974.PubMedCrossRefGoogle Scholar
  19. 19.
    Fitzpatrick, G. F., Meguid, M. M., Gitlitz, P., O’Connor, N. E., and Brennan, M. F.: Effects of glucagon on 3-methylhistidine excretion: muscle proteolysis or ureogenesis? Surg. Forum, 26:46, 1975.PubMedGoogle Scholar
  20. 20.
    Wurtman, R. J.: Catecholamines. New Eng. J. Med., 273: 637, 1965.PubMedCrossRefGoogle Scholar
  21. 21.
    Axelrod, J., and Weinshilboum, R.: Catecholamines. New Eng. J. Med., 287:237, 1972.PubMedCrossRefGoogle Scholar
  22. 21.
    Von Euler, U. S.: Quantitation of stress by catecholamine analysis. Clin, Pharm, Therap, 5:398, 1964.Google Scholar
  23. 23.
    Geffen, L.: Serum dopamine β-hydroxylase as an index of sympathetic function. Life Sci., 14:1593, 1974.PubMedCrossRefGoogle Scholar
  24. 24.
    Goodall, McC, and Alton, H.: Dopamine (3-hydroxytyramine) replacement and metabolism in sympathetic nerve and adrenal medullary depletions after prolonged thermal injury.J. Clin. Invest., 48:1761, 1969.PubMedCrossRefGoogle Scholar
  25. 25.
    Cannon, W. B.: The Wisdom of the Body. New York, Norton, pp. 177–201, 1967.Google Scholar
  26. 26.
    Robinson, G. A., Butcher, R. W., and Sutherland, E. W.: Cyclic AMP. New York, Academic Press, 1971, p. 145.Google Scholar
  27. 27.
    Brodie, B. B., Davies, J. I., Hynie, S., Krishna, G., and Weiss, B.: Interrelationships of catecholamines with other endocrine systems. Pharm. Rev., 18:273, 1966.PubMedGoogle Scholar
  28. 28.
    Horwitz, B. A.: Ouabain-sensitive component of brown fat thermogenesis. Amer. J. Physiol., 224:352, 1973.PubMedGoogle Scholar
  29. 29.
    Hume, D. M., and Egdahl, R. H.: The importance of the brain in the endocrine response to injury. Ann. Surg., 150:697, 1959.PubMedCrossRefGoogle Scholar
  30. 30.
    Ingle, D. J., Meeks, R.C., and Thomas, K. E.: The effect of fractures upon urinary electrolytes in non-adrenalectomized rats and in adrenalectomized rats treated with adrenal cortex extract. Endocrinology, 49:703, 1951.PubMedCrossRefGoogle Scholar
  31. 31.
    Owens, O. E., and Canili, G. F., Jr.: Metabolic effects of exogenous glucocorticoids in fasting man.J. Clin. Invest., 52:2596, 1973.CrossRefGoogle Scholar
  32. 32.
    Beisel, W. R., Sawyer, W. D., Ryll, E. D., and Crozier, D.: Metabolic effects of intracellular infections in man. Ann. Int. Med., 67:744, 1967.PubMedGoogle Scholar
  33. 33.
    Wilmore, D. W., Moylan, J. A., Jr., Bristow, B. F., Mason, A. D., Jr., and Pruitt, B. A., Jr.: Anabolic effects of human growth hormone and high caloric feedings following thermal injury. Surg. Gynecol Obstet, 138:875, 1974.PubMedGoogle Scholar
  34. 34.
    Burr, W. A., Griffiths, R. S., Black, E. G., and Hoffenberg, R.: Serum triiodothyronine and reverse triiodothyronine concentrations after surgical operations. Lancet, 2:1277, 1975.PubMedCrossRefGoogle Scholar
  35. 35.
    Becker, R., Johnson, D. W., Woeber, K. A., and Wilmore, D. W.: Decreased serum triiodothyronine (T3) following thermal injury. Fed. Proc., 35:216, 1976.Google Scholar
  36. 36.
    Spaulding, S. W., Chopra, I. J., Sherwin, R. S., and Lyall, S. S.: Effect of caloric restriction and dietary composition in serum T3 and reversed T3 in man.J. Clin. Endocr. Metab., 42:197, 1976.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1977

Authors and Affiliations

  • Douglas W. Wilmore
    • 1
  1. 1.U. S. Army Institute of Surgical ResearchBrooke Army Medical CenterFort Sam HoustonUSA

Personalised recommendations